Logo for the University of Illinois at Chicago
    • Login
    View Item 
    •   INDIGO Home
    • Pharmacy, College of
    • Pharmacy Practice, Department of
    • Publications - Pharmacy Practice
    • View Item
    •   INDIGO Home
    • Pharmacy, College of
    • Pharmacy Practice, Department of
    • Publications - Pharmacy Practice
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Vitamin D Receptor Activation Mitigates the Impact of Uremia on Endothelial Function in the 5/6 Nephrectomized Rats

    Thumbnail
    View/Open
    Vitamin D Receptor Activation Mitigates the Impact of Uremia on Endothelial Function in the Nephrectomized Rats.pdf (1.008Mb)
    Date
    2010
    Author
    Wuwong, Jinshyun Ruth
    Noonan, William
    Nakane, Masaki
    Brooks, Kristin A.
    Segreti, Jason A.
    Polakowski, James S.
    Cox, Bryan
    Publisher
    Hindawi Publishing Corporation
    Metadata
    Show full item record
    Abstract
    Endothelial dysfunction increases cardiovascular disease risk in chronic kidney disease (CKD). This study investigates whether VDR activation affects endothelial function in CKD. The 5/6 nephrectomized (NX) rats with experimental chronic renal insufficiency were treated with or without paricalcitol, a VDR activator. Thoracic aortic rings were precontracted with phenylephrine and then treated with acetylcholine or sodium nitroprusside. Uremia significantly affected aortic relaxation (-50.0 +/- 7.4% in NX rats versus -96.2 +/- 5.3% in SHAM at 30 mu M acetylcholine). The endothelial-dependent relaxation was improved to -58.2 +/- 6.0%, -77.5 +/- 7.3%, and -90.5 +/- 4.0% in NX rats treated with paricalcitol at 0.021, 0.042, and 0.083 mu g/kg for two weeks, respectively, while paricalcitol at 0.042 mu g/kg did not affect blood pressure and heart rate. Parathyroid hormone (PTH) suppression alone did not improve endothelial function since cinacalcet suppressed PTH without affecting endothelial-dependent vasorelaxation. N-omega-nitro-L-arginine methyl ester completely abolished the effect of paricalcitol on improving endothelial function. These results demonstrate that VDR activation improves endothelial function in CKD.
    Subject
    endothelial
    nephrectomized
    Type
    Article
    Date available in INDIGO
    2011-05-27T20:33:18Z
    URI
    http://hdl.handle.net/10027/7793
    Collections
    • Publications - Pharmacy Practice

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV

    Browse

    All of INDIGOCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV